Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
Insurance debt valuations have taken a hit as the Covid-19 coronavirus has spread across the world. In the short term the sector is worried about suffering an indirect impact from the outbreak, but companies are also braced for more claims if the virus reaches pandemic status. -
A seller pulled a $175m BWIC — bids wanted in competition — scrapping an attempt to offload a list of CLO triple-A bonds as the Covid-19 coronavirus spurred more volatility in the market midweek.
-
The World Bank has surprised onlookers with a five year benchmark bond, printed into the teeth of the volatility caused by Covid-19 and an emergency rate cut from the Federal Reserve. The successful deal from the supranational has emboldened an agency to follow suit, with others expected to follow.
-
One of the derivatives industry’s largest annual conferences was cancelled on Tuesday, after the spread of the Covid-19 coronavirus made the event unviable in the view of the organisers.
-
Coronavirus fears and plunging markets meant a flood of pulled deals in leveraged loans — but a strong backdrop for some, notably French medical diagnostics and testing business Biogroup-LCD which launched a €274.7m acquisition loan into general syndication through JP Morgan and Natixis on Tuesday.
-
The US Federal Reserve’s emergency 50bp cut in interest rates on Tuesday failed to reassure markets. The US and European response to the Covid-19 coronavirus outbreak needs to incorporate targeted fiscal policy as well.
